A study from Weill Cornell Medicine provides new insights into a pair of proteins and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver’s fight against tumors.
Study opens the door to exploring new targets for therapies for fibrolamellar carcinoma, which does not respond to conventional treatments and leaves patients with approximately a year to live on average once it is detected.
Researchers have identified the origin of ovarian cancer that develops in the fallopian tube, which opens doors to discovering new methods for diagnosing the disease and potential therapies.
Cornell Human Ecology faculty members Denise Green ’07 and Laura Bellows have recently been awarded fellowships in the Bronfenbrenner Center for Translational Research (BCTR).
The study paves the way for using the novel manufacturing process and quality controls to move cell therapy production further along toward applying it in a clinic.
As French authorities face widespread reports of a bedbug infestation in Paris, Jody Gangloff-Kaufmann, a Cornell University entomologist whose work focuses on reducing pest risks, provides some tips of what to look for and how to salvage exposed belongings.
Researchers have discovered a protein called SEL1L that plays a critical role in clearing collagen from tissue, and which may be a therapeutic target to help prevent fibrosis, scar tissue that interferes with organ function.
Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before risk of contracting the potentially fatal infection dramatically increases in adolescence.
The study shows that artificial intelligence and machine learning technologies can effectively and efficiently subtype pathology samples from patients with rheumatoid arthritis.
Researchers at Weill Cornell Medicine have developed a powerful new technique to generate “movies” of changing protein structures at speeds of up to 50 frames per second.
